132 related articles for article (PubMed ID: 33177357)
1. Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
Malleo G; Maggino L; Qadan M; Marchegiani G; Ferrone CR; Paiella S; Luchini C; Mino-Kenudson M; Capelli P; Scarpa A; Lillemoe KD; Bassi C; Castillo CF; Salvia R
Ann Surg; 2022 Nov; 276(5):e518-e526. PubMed ID: 33177357
[TBL] [Abstract][Full Text] [Related]
2. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.
Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study.
Zheng ZJ; Wang MJ; Tan CL; Chen YH; Ping J; Liu XB
Medicine (Baltimore); 2020 Feb; 99(8):e19327. PubMed ID: 32080152
[TBL] [Abstract][Full Text] [Related]
4. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
[TBL] [Abstract][Full Text] [Related]
5. Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy.
Javed AA; Ding D; Baig E; Wright MJ; Teinor JA; Mansoor D; Thompson E; Hruban RH; Narang A; Burns WR; Burkhart RA; Lafaro K; Weiss MJ; Cameron JL; Wolfgang CL; He J
World J Surg; 2022 Mar; 46(3):667-677. PubMed ID: 34994834
[TBL] [Abstract][Full Text] [Related]
6. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.
Fu N; Wang W; Cheng D; Wang J; Xu Z; Deng X; Peng C; Chen H; Shen B
Pancreatology; 2021 Jun; 21(4):724-730. PubMed ID: 33642141
[TBL] [Abstract][Full Text] [Related]
7. Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinoma.
Pu N; Gao S; Beckman R; Ding D; Wright M; Chen Z; Zhu Y; Hu H; Yin L; Beckman M; Thompson E; Hruban RH; Cameron JL; Gage MM; Lafaro KJ; Burns WR; Wolfgang CL; He J; Yu J; Burkhart RA
HPB (Oxford); 2021 Apr; 23(4):575-586. PubMed ID: 32900612
[TBL] [Abstract][Full Text] [Related]
8. Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study.
Goess R; Jäger C; Perinel J; Pergolini I; Demir E; Safak O; Scheufele F; Schorn S; Muckenhuber A; Adham M; Novotny A; Ceyhan GO; Friess H; Demir IE
BJS Open; 2024 Jan; 8(1):. PubMed ID: 38271272
[TBL] [Abstract][Full Text] [Related]
9. A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database.
Wang W; Shen Z; Zhang J; Chen H; Deng X; Peng C; Xie J; Xu Z; Shen B
Ann Surg Oncol; 2022 Mar; 29(3):1533-1539. PubMed ID: 34622372
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories.
Strobel O; Hinz U; Gluth A; Hank T; Hackert T; Bergmann F; Werner J; Büchler MW
Ann Surg; 2015 May; 261(5):961-9. PubMed ID: 24979603
[TBL] [Abstract][Full Text] [Related]
11. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Koerkamp BG; van Santvoort HC; Grützmann R; Besselink MG; Schrotz-King P; Brenner H
Ann Surg; 2021 Dec; 274(6):e554-e563. PubMed ID: 31425290
[TBL] [Abstract][Full Text] [Related]
12. Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol.
Malleo G; Maggino L; Casciani F; Lionetto G; Nobile S; Lazzarin G; Paiella S; Esposito A; Capelli P; Luchini C; Scarpa A; Bassi C; Salvia R
Ann Surg Oncol; 2022 Jun; 29(6):3477-3488. PubMed ID: 35192154
[TBL] [Abstract][Full Text] [Related]
13. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
Li HJ; Chen YT; Yuan SQ
Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
[TBL] [Abstract][Full Text] [Related]
14. A Single-Institution Validation Study of Lymph Node Staging By the AJCC 8th Edition for Patients with Pancreatic Head Cancer: A Proposal to Subdivide the N2 Category.
Asano D; Nara S; Kishi Y; Esaki M; Hiraoka N; Tanabe M; Shimada K
Ann Surg Oncol; 2019 Jul; 26(7):2112-2120. PubMed ID: 31037440
[TBL] [Abstract][Full Text] [Related]
15. Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma.
Pu N; Chen Q; Gan W; Shen Y; Gao S; Habib JR; Yin H; Zhang J; Kinny-Köster B; Cui M; Li J; Dong Y; Nagai M; Liu L; Yu J; Wu W; Lou W
Adv Ther; 2021 Aug; 38(8):4258-4270. PubMed ID: 34176089
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of lymph node dissection of No. 14cd during pancreaticoduodenectomy in patients with pancreatic head carcinoma].
Wu PF; Zhang K; Tian L; Yin J; Wei JS; Xi CH; Chen JM; Guo F; Lu ZP; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2023 Jul; 61(7):582-589. PubMed ID: 37402687
[No Abstract] [Full Text] [Related]
17. International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.
van Roessel S; Kasumova GG; Verheij J; Najarian RM; Maggino L; de Pastena M; Malleo G; Marchegiani G; Salvia R; Ng SC; de Geus SW; Lof S; Giovinazzo F; van Dam JL; Kent TS; Busch OR; van Eijck CH; Koerkamp BG; Abu Hilal M; Bassi C; Tseng JF; Besselink MG
JAMA Surg; 2018 Dec; 153(12):e183617. PubMed ID: 30285076
[TBL] [Abstract][Full Text] [Related]
18. N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma.
Valsangkar NP; Bush DM; Michaelson JS; Ferrone CR; Wargo JA; Lillemoe KD; Fernández-del Castillo C; Warshaw AL; Thayer SP
J Gastrointest Surg; 2013 Feb; 17(2):257-66. PubMed ID: 23229885
[TBL] [Abstract][Full Text] [Related]
19. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
[TBL] [Abstract][Full Text] [Related]
20. Exploration of the lymphadenectomy strategy for elderly pancreatic ductal adenocarcinoma patients undergoing curative-intent resection.
Li Z; Zhang X; Guo C; Sun C; Li Z; Fei H; Chen Y; Zhao D
Am J Cancer Res; 2023; 13(5):1938-1951. PubMed ID: 37293173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
